The clinical impression of severity index for Parkinson's disease: International validation study

Movement Disorders

Volumn 24, Issue 2, 2009, Pages 211-217

  Martínez Martín, Pablo ^a   Rodríguez Blázquez, Carmen ^a   Forjaz, Maria João ^a   de Pedro, Jesús ^a   Aguilar, M ^b   Alvarez Sauco M ^c   Bayes A ^d   Blazquez M ^e   Bergareche, A ^f   Campos, V ^g   Carballo, M ^h   Catalan M J ⁱ   Chacon J ^j   Cubo, E ^k   Fernandez Garcia J M ^l   LInazasoro, G ^m   Lopez del Val J ⁿ   Martinez Castrillo J C ^o   Mendoza, A ^p   Mir, P ^h   Kulisevsky, J ^q   Valldeoriola, F ^r   Vela, L ^s   Vivancos, F ^t   Virues J ^u   Arroyo, S ^u   Frades, B ^u   Carod Artal, F J ^v   Micheli, F ^w   Serrano Duenas M ^x   Galeano, G ^y   Meza Rojas, G ^y   Velazquez C ^y   more..

^a INSTITUTO DE SALUD CARLOS III   (Spain)

^b HOSPITAL MÚTUA DE TERRASSA   (Spain)

^c HOSPITAL GENERAL UNIVERSITARIO DE ELCHE   (Spain)

^d CENTRO MÉDICO TEKNON   (Spain)

^e HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^f Hospital Bidasoa   (Spain)

^g Hospital Vithas Xanit Internacional   (Spain)

^h HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

ⁱ HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^j HOSPITAL UNIVERSITARIO VIRGEN MACARENA   (Spain)

^k Burgos Hospital   (Spain)

^l HOSPITAL DE BASURTO   (Spain)

^m Gipuzkoa Polyclinic   (Spain)

ⁿ Lozano Blesa Hospital   (Spain)

^o HOSPITAL RAMÓN Y CAJAL   (Spain)

^p HOSPITAL GENERAL DE SEGOVIA   (Spain)

^q HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^r HOSPITAL CLÍNIC   (Spain)

^s HOSPITAL UNIVERSITARIO FUNDACIÓN ALCORCÓN   (Spain)

^t HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^u CARLOS III INSTITUTE OF HEALTH   (Spain)

^v SARAH NETWORK OF REHABILITATION HOSPITALS   (Brazil)

^w HOSPITAL DE CLÍNICAS JOSÉ DE SAN MARTÍN   (Argentina)

^x HOSPITAL CARLOS ANDRADE MARÍN   (Ecuador)

^y Central Social Security Hospital Previsión Social   (Paraguay)

more..

Author keywords

Assessment; Clinical impression of severity index; Global impression of severity; Parkinson's disease; Rating scales

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL IMPRESSION OF SEVERITY INDEX FOR PARKINSON DISEASE; CONTROLLED STUDY; DEPRESSION; DISCRIMINANT VALIDITY; DISEASE DURATION; DISEASE SEVERITY; FEMALE; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; PARKINSON DISEASE; PRIORITY JOURNAL; PSYCHOLOGICAL RATING SCALE; PSYCHOMETRY; QUESTIONNAIRE; VALIDATION STUDY;

AGED; COGNITION; CROSS-SECTIONAL STUDIES; CULTURAL CHARACTERISTICS; DISABILITY EVALUATION; FEMALE; HUMANS; MALE; MIDDLE AGED; MOTOR SKILLS; NEUROPSYCHOLOGICAL TESTS; PARKINSON DISEASE; PSYCHOMETRICS; SEVERITY OF ILLNESS INDEX; SOCIOECONOMIC FACTORS;

EID: 61649085932     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.22320     Document Type: Article

References (38)

1. Hoehn MM, Yahr MD. Parkisonism: onset, progression, and mortality. Neurology 1967;17:427-442.
2. Schwab RS, England S. Projection technique for evaluating surgery in Parkinson's disease. In: Gillingham FJ, Donalson IML, editors. Third symposium on Parkinson's disease. Edinburgh: Livingstone; 1969; p 152-157.
3. Guy W. Early Clinical Drug Evaluation Unit (ECDEU) assessment manual for psychopharmacology, revised. Bethesda, MD: National Institute of Mental Health; 1976. p 217-222.
4. Martinez-Martin P, Forjaz MJ, Cubo E, et al. Global versus factor-related impression of severity in Parkinson's disease: a new clinimetric index (CISI-PD). Mov Disord 2006;21:208-214.
5. ELEP Group. [A longitudinal study of patients with Parkinson's disease (ELEP): aims and methodology]. Rev Neurol 2006;42: 360-365.
6. Gibb WR, Lees AJ. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry 1988;51:745-752.
7. Marinus J, Visser M, Stiggelbout AM, et al. A short scale for the assessment of motor impairments and disabilities in Parkinson's disease: the SPES/SCOPA. J Neurol Neurosurg Psychiatry 2004; 75:388-395.
8. Marinus J, Visser M, Verwey NA, et al. Assessment of cognition in Parkinson's disease. Neurology 2003;61:1222-1228.
9. Miller MD, Towers AA. A manual of guidelines for scoring the Cumulative Illness Rating Scale for Geriatrics (CIRS-G). Pittsburgh: University of Pittsburgh; 1991.
10. Visser M, Marinus J, Van Hilten JJ, et al. Assessing comorbidity in patients with Parkinson's disease. Mov Disord 2004;19:824-828.
11. Snaith RP, Zigmond AS. Hospital Anxiety and Depression Scale (HADS). In: Rush AJ, editors. Handbook of psychiatric measures. Washington D.C.: American Psychiatric Association; 2000. p 547-548.
12. Marinus J, Leentjens AF, Visser M, et al. Evaluation of the hospital anxiety and depression scale in patients with Parkinson's disease. Clin Neuropharmacol 2002;25:318-324.
13. Marinus J, Visser M, Martinez-Martin P, et al. A short psychosocial questionnaire for patients with Parkinson's disease: the SCOPA-PS. J Clin Epidemiol 2003;56:61-67.
14. McHorney CA, Tarlov AR. Individual-patient monitoring in clinical practice: are available health status surveys adequate? Qual Life Res 1995;4:293-307.
15. Holmes W, Bix B, Shea J. SF-20 score and item distributions in a human immunodeficiency virus-seropositive sample. Med Care 1996;34:562-569.
16. Scientific Advisory Committee of the Medical Outcomes Trust. Assessing health status and quality-of-life instruments: attributes and review criteria. Qual Life Res 2002;11:193-205.
17. Eisen M, Ware JE, Jr, Donald CA, Brook RH. Measuring components of children's health status. Med Care 1979;17:902-921.
18. Jenkinson C, Fitzpatrick R, Norquist J, et al. Cross-cultural evaluation of the Parkinson's Disease Questionnaire: tests of data quality, score reliability, response rate, and scaling assumptions in the United States, Canada, Japan, Italy, and Spain. J Clin Epidemiol 2003;56:843-847.
19. Bentler P, Wu E. EQS for Windows user's guide. Encino: Multivariate Software; 1995.
20. Carmines EG, McIver JP. Analyzing models with unobserved variables: analysis of covariance structures. In: Bornstedt GW, Borgatta EF, editors. Social measurement: current issues. Beverly Hills: Sage Publications; 1981. p 65-112.
21. Browne MW, Cudeck R. Alternative ways of assessing model fit. In: Bollen KA, Long LS, editors. Testing structural equation models. Newbury Park: Sage Publications; 1993. p 136-62.
22. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977;33:159-174.
23. Wyrwich KW, Nienaber NA, Tierney WM, Wolinsky FD. Linking clinical relevance and statistical significance in evaluating intra-individual changes in health-related quality of life. Med Care 1999;37:469-478.
24. Beckerman H, Roebroeck ME, Lankhorst GJ, et al. Smallest real difference, a link between reproducibility and responsiveness. Qual Life Res 2001;10:571-578.
25. Wyrwich KW, Wolinsky FD. Identifying meaningful intra-individual change standards for health-related quality of life measures. J Eval Clin Pract 2000;6:39-49.
26. Swinscow TDV. Correlation and regression. Statistics at Square One, 9th edition. London: BMJ Publishing Group; 1997.
27. Shrive FM, Stuart H, Quan H, Ghali WA. Dealing with missing data in a multi-question depression scale: a comparison of imputation methods. BMC Med Res Methodol 2006;6:57.
28. Martinez-Martin P, Benito-Leon J, Burguera JA, et al. The SCOPA-Motor Scale for assessment of Parkinson's disease is a consistent and valid measure. J Clin Epidemiol 2005;58:674-679.
29. Martinez-Martin P, Forjaz MJ. Metric attributes of the unified Parkinson's disease rating scale 3.0 battery. I. feasibility, scaling assumptions, reliability, and precision. Mov Disord 2006;21: 1182-1188.
30. Bennett DA, Shannon KM, Beckett LA, et al. Metric properties of nurses' ratings of parkinsonian signs with a modified Unified Parkinson's Disease Rating Scale. Neurology 1997;49:1580-1587.
31. Camicioli R, Grossmann SJ, Spencer PS, et al. Discriminating mild parkinsonism: methods for epidemiological research. Mov Disord 2001;16:33-40.
32. Wyrwich KW, Tierney WM, Wolinsky FD. Further evidence supporting an SEM-based criterion for identifying meaningful intra-individual changes in health-related quality of life. J Clin Epidemiol 1999;52:861-873.
33. Beaton DE, Bombardier C, Katz JN, Wright JG. A taxonomy for responsiveness. J Clin Epidemiol 2001;54:1204-1217.
34. Nunnally JC, Bernstein IH. Psychometric theory. New York: McGraw-Hill; 1994. p 211-292.
35. Norman GR, Sloan JA, Wyrwich KW. Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation. Med Care 2003;41:582-592.
36. Wyrwich KW, Bullinger M, Aaronson N, et al. Estimating clinically significant differences in quality of life outcomes. Qual Life Res 2005;14:285-295.
37. de Vet HC, Terwee CB, Ostelo RW, Beckerman H, Knol DL, Bouter LM. Minimal changes in health status questionnaires: distinction between minimally detectable change and minimally important change. Health Qual Life Outcomes 2006;4:54.
38. Goetz CG, Poewe W, Rascol O, et al. Movement disorder society task force report on the Hoehn and Yahr Staging Scale: status and recommendations. Mov Disord 2004;19:1020-1028.